About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:5490471
Allelic
Composition
Vps54wr/Vps54wr
Genetic
Background
involves: C57BL/6J * C57BL/Fa
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Vps54wr mutation (3 available); any Vps54 mutation (239 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
• microglia activation accompanies motor neuron degeneration (J:181019)
• microglia activation accompanies motor neuron degeneration (J:181019)
• reactive gliosis accompanies motor neuron degeneration (J:181019)
• reactive gliosis accompanies motor neuron degeneration (J:181019)
• decrease in density of parvalbumin-positive neurons in layer 5 of the primary motor cortex (J:181019)
• decrease in density of somatostatin-positive neurons in layer 5 of the primary motor cortex (J:181019)
• decrease in optical density of GABAergic synaptic boutons as assessed by VGAT staining in layer 5 of the primary motor cortex (J:181019)
• decrease in density of parvalbumin-positive neurons in layer 5 of the primary motor cortex (J:181019)
• decrease in density of somatostatin-positive neurons in layer 5 of the primary motor cortex (J:181019)
• decrease in optical density of GABAergic synaptic boutons as assessed by VGAT staining in layer 5 of the primary motor cortex (J:181019)
• decrease in optical density of GABAergic synaptic boutons as assessed by VGAT staining in layer 5 of the primary motor cortex (J:181019)
• decrease in optical density of GABAergic synaptic boutons as assessed by VGAT staining in layer 5 of the primary motor cortex (J:181019)
• layer 5 pyramidal neurons exhibit increased excitability as a result of decreased GABAergic inhibition (J:181019)
• layer 5 pyramidal neurons exhibit increased excitability as a result of decreased GABAergic inhibition (J:181019)
• mutant mice exhibit a down regulation in phasic and tonic GABA(a) receptor-mediated currents (J:181019)
• mice exhibit an 87% reduction in average tonic current densities (pA/pF) as compared to controls (J:181019)
• input resistance in layer 5 pyramidal neurons is increased in mutant mice as compared to controls (J:181019)
• current threshold is significantly lower in mutant mice, however polarization voltage is similar between mutant and control (J:181019)
• mutant mice exhibit a down regulation in phasic and tonic GABA(a) receptor-mediated currents (J:181019)
• mice exhibit an 87% reduction in average tonic current densities (pA/pF) as compared to controls (J:181019)
• input resistance in layer 5 pyramidal neurons is increased in mutant mice as compared to controls (J:181019)
• current threshold is significantly lower in mutant mice, however polarization voltage is similar between mutant and control (J:181019)
• individual spontaneous inhibitory post synaptic currents (sIPSC) display smaller amplitudes, however mean amplitude is not statistically different in whole-cell voltage-clamp recordings from layer 5 pyramidal neurons (J:181019)
• sIPSC frequency is 28% lower than controls (J:181019)
• individual spontaneous inhibitory post synaptic currents (sIPSC) display smaller amplitudes, however mean amplitude is not statistically different in whole-cell voltage-clamp recordings from layer 5 pyramidal neurons (J:181019)
• sIPSC frequency is 28% lower than controls (J:181019)
• whole cell recordings of miniature IPSC (mIPSC) in layer 5 pyramidal neurons detect an increase in weighted decay time constant, but no differences in amplitude or rise time (J:181019)
• mIPSC frequency is 36% lower than controls (J:181019)
• whole cell recordings of miniature IPSC (mIPSC) in layer 5 pyramidal neurons detect an increase in weighted decay time constant, but no differences in amplitude or rise time (J:181019)
• mIPSC frequency is 36% lower than controls (J:181019)

muscle
• mice develop muscle weakness in the forelimbs beginning at 3-4 weeks (J:181019)
• mice develop muscle weakness in the forelimbs beginning at 3-4 weeks (J:181019)

immune system
• microglia activation accompanies motor neuron degeneration (J:181019)
• microglia activation accompanies motor neuron degeneration (J:181019)

hematopoietic system
• microglia activation accompanies motor neuron degeneration (J:181019)
• microglia activation accompanies motor neuron degeneration (J:181019)

Mouse Models of Human Disease
OMIM ID Ref(s)
Amyotrophic Lateral Sclerosis 1; ALS1 105400 J:181019 , J:196432


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Tumor Biology (MTB), Gene Ontology (GO), MouseCyc
Citing These Resources
Funding Information
Warranty Disclaimer & Copyright Notice
Send questions and comments to User Support.
last database update
01/26/2016
MGI 6.02
The Jackson Laboratory